INOVIO Reports First Quarter 2026 Financial Results and Recent Business Highlights

B Biologics License Application (BLA) for INO-3107 actively being reviewed under the accelerated approval program by the U.S. Food and Drug Administration (FDA) with a…
posteditor
posteditor
Articles: 17424